SynDevRx
Developer of therapeutic approaches designed to target the metabolic drivers and vascular factors that influence cancer progression. The company offers treatments grounded in metabo oncology and suppo...
Valuation
$120M
Latest known
Share Price
N/A
Total Raised
$124.2M
Last Round
N/A